adipose tissue
• increased size of adipocytes
|
• aberrant accumulation of abdominal fat by 2 months of age
|
growth/size/body
homeostasis/metabolism
• elevation in plasma leptin at 19 weeks
|
hyperglycemia
(
J:92404
)
• mild hyperglycemia by 2 months of age, persisting to at least 6 months
|
• glucose intolerance by two months of age
|
• insulin resistance by two months of age
• adipocytes exhibit defective response to exogenous insulin
|
• low levels of plasma adiponectin, ~50% decrease at 8 and 19 weeks
|
• dyslipidemia
• increase in size and number of lipid droplets in bone marrow derived granulocytes and macrophages
|
• greater than 2 fold increase in cholesterol associated with VLDL and LDL at 19 weeks, smaller increase in HDL
|
• elevated plasma nonesterified fatty acid levels by 19 weeks
|
• at 19 weeks
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
obesity | DOID:9970 |
OMIM:601665 |
J:92404 |